Orion reported EUR542.2M in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
Almirall EUR 602.71M 55.09M Jun/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Oriola-kd EUR 53M 3.2M Sep/2026
Raisio Oyj EUR 56M 1.5M Jun/2026
Recordati EUR 672M 9.35M Sep/2026
UCB EUR 4.25B 764M Dec/2025